Literature DB >> 26031706

Comparison of EGFR mutation detection between the tissue and cytology using direct sequencing, pyrosequencing and peptide nucleic acid clamping in lung adenocarcinoma: Korean multicentre study.

Kyueng-Whan Min1, Wan-Seop Kim2, Se Jin Jang3, Yoo Duk Choi4, Sunhee Chang5, Soon Hee Jung6, Lucia Kim7, Mee Sook Roh8, Choong Sik Lee9, Jung Weon Shim10, Mi Jin Kim11, Geon Kook Lee12.   

Abstract

BACKGROUND: The importance of sensitive methods for the detection of epidermal growth factor receptor (EGFR) mutation is emphasized. The aim of this study is to perform comparative and concordance analyses of direct sequencing, pyrosequencing and peptide nucleic acid (PNA) clamping for detecting EGFR gene mutations using archived tissue and cytology specimens.
METHODS: Samples from a total of 112 cases, which were diagnosed with adenocarcinoma of the lung at nine hospitals in Korea were collected. Using the above three methods, the concordance rates of EGFR mutations in exons 18, 19, 20 and 21 were analysed and validated in comparative tissue and cytology specimens.
RESULTS: Comparison of EGFR mutation detection between the tissue and cytology had a high concordance rate. The diagnostic performance of pyrosequencing and PNA clamping in tissue was higher than that of direct sequencing as well as cytology. Additionally, among some of the patients who had EGFR wild type by single method, EGFR mutations were detected by other methods. Cytology specimens had a diagnostic performance for the detection of EGFR mutations.
CONCLUSIONS: Cytology specimens had a diagnostic performance for the detection of EGFR mutations that was comparable to that of tissues. For detecting EGFR mutations, pyrosequencing or PNA clamping was more sensitive than direct sequencing. In EGFR mutation negative patients who are difficult to obtain tissue, repeating test using pyrosequencing or PNA clamping is recommended to improve the detection rate of EGFR mutation than only one, especially in cytology.
© The Author 2015. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26031706     DOI: 10.1093/qjmed/hcv103

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  8 in total

1.  Bronchial brushing cytology is comparable to bronchial biopsy for epidermal growth factor receptor mutation test in non-small cell lung cancer.

Authors:  Joo-Yeon Koo; Nah-Ihm Kim; Taebum Lee; Yoo-Duk Choi
Journal:  Cytojournal       Date:  2020-07-16       Impact factor: 2.091

2.  Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer.

Authors:  Seung Eun Lee; So-Young Lee; Hyung-Kyu Park; Seo-Young Oh; Hee-Joung Kim; Kye-Young Lee; Wan-Seop Kim
Journal:  J Korean Med Sci       Date:  2016-05-12       Impact factor: 2.153

Review 3.  Peptide Nucleic Acid Clamping and Direct Sequencing in the Detection of Oncogenic Alterations in Lung Cancer: Systematic Review and Meta-Analysis.

Authors:  Jae Uk Song; Jonghoo Lee
Journal:  Yonsei Med J       Date:  2018-03       Impact factor: 2.759

4.  Prevalence of Epidermal Growth Factor Receptor Mutations in Patients with Non-Small Cell Lung Cancer in Turkish Population.

Authors:  Gaye Güler Tezel; Ebru Şener; Çisel Aydın; Sevgen Önder
Journal:  Balkan Med J       Date:  2017-08-23       Impact factor: 2.021

5.  Recent Trends of Lung Cancer in Korea.

Authors:  Jae Guk Lee; Ho Cheol Kim; Chang-Min Choi
Journal:  Tuberc Respir Dis (Seoul)       Date:  2021-02-10

Review 6.  Epidemiology of Lung Cancer in Korea: Recent Trends.

Authors:  Ji Young Park; Seung Hun Jang
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-03-31

7.  Comparison of Epidermal Growth Factor Receptor Mutations between Metastatic Lymph Node Diagnosed by EBUS-TBNA and Primary Tumor in Non-Small Cell Lung Cancer.

Authors:  Hyo Jae Kang; Bin Hwangbo; Jin Soo Lee; Moon Soo Kim; Jong Mog Lee; Geon-Kook Lee
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

8.  Detection of Rare Mutations in EGFR-ARMS-PCR-Negative Lung Adenocarcinoma by Sanger Sequencing.

Authors:  Chaoyue Liang; Zhuolin Wu; Xiaohong Gan; Yuanbin Liu; You You; Chenxian Liu; Chengzhi Zhou; Ying Liang; Haiyun Mo; Allen M Chen; Jiexia Zhang
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.